Hims Hers Health Inc Asset Resilience Ratio
Hims Hers Health Inc asset resilience ratio. Hims Hers Health Inc (HIMS) has an Asset Resilience Ratio of 6.37% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HIMS days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hims Hers Health Inc (2019–2025)
Asset resilience ratio of Hims Hers Health Inc from 2019 to 2025. This chart shows how Hims Hers Health Inc's Asset Resilience Ratio has changed over time. Read HIMS liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Hims Hers Health Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hims Hers Health Inc (HIMS) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $231.24 Million | 6.37% |
| Total Liquid Assets | $231.24 Million | 6.37% |
Asset Resilience Insights
- Limited Liquidity: Hims Hers Health Inc maintains only 6.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hims Hers Health Inc Industry Peers by Asset Resilience Ratio
Compare Hims Hers Health Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Hims Hers Health Inc Asset Resilience Ratio by Year (2019–2025)
Hims Hers Health Inc asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for Hims Hers Health Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 16.19% | $348.88 Million | $2.15 Billion | +4.93pp |
| 2024-12-31 | 11.26% | $79.67 Million | $707.54 Million | -16.92pp |
| 2023-12-31 | 28.18% | $124.32 Million | $441.19 Million | -8.09pp |
| 2022-12-31 | 36.26% | $132.85 Million | $366.34 Million | -5.46pp |
| 2021-12-31 | 41.73% | $175.49 Million | $420.58 Million | -19.66pp |
| 2020-12-31 | 61.39% | $72.86 Million | $118.70 Million | +9.05pp |
| 2019-12-31 | 52.34% | $37.72 Million | $72.07 Million | -- |
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available … Read more